Table 3

HRs (95% CIs) for death from CVD, non-CVD, and all causes for group II compared with group I

Model 1Model 2Model 3
Men
    n12,56612,5669,978
    CVD1.16 (1.01–1.34)1.22 (1.05–1.41)1.25 (1.05–1.50)
    Non-CVD1.01 (0.86–1.19)1.09 (0.92–1.29)1.09 (0.89–1.34)
    All causes1.10 (0.99–1.22)1.16 (1.04–1.30)1.18 (1.03–1.35)
Women
    n10,87410,8747,350
    CVD1.23 (0.91–1.65)1.40 (1.03–1.89)1.60 (1.03–2.48)
    Non-CVD0.92 (0.73–1.15)0.99 (0.79–1.25)1.05 (0.78–1.42)
    All causes1.03 (0.86–1.23)1.13 (0.94–1.35)1.18 (0.93–1.51)
  • Model 1: adjusted for age and cohort; model 2: model 1 plus fasting plasma glucose, BMI, total cholesterol, smoking and hypertension status; model 3: model 2 plus fasting insulin. Group I, 2-h plasma glucose ≤ FPG; group II, 2-h plasma glucose > FPG.